The role of salvage surgery in the treatment of a gefitinib-resistant non-small cell lung cancer patient: a case report

被引：7
|
作者：
Zang, Jing [1 ,2 ]
Horinouchi, Hidehito [3 ]
Hanaoka, Jun [4 ]
Funai, Kazuhito [5 ]
Sakakura, Noriaki [6 ]
Liao, Hu [7 ]
机构：
[1] Sichuan Univ, West China Univ Hosp 2, Dept Ultrasound, West China Womens & Childrens Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Peoples R China
[3] Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tokyo, Japan
[4] Shiga Univ Med Sci, Dept Surg, Div Gen Thorac Surg, Otsu, Shiga, Japan
[5] Hamamatsu Univ Sch Med, Dept Surg 1, Higashi Ku, Hamamatsu, Shizuoka, Japan
[6] Aichi Canc Ctr Hosp, Dept Thorac Surg, Chikusa Ku, Nagoya, Aichi, Japan
[7] Sichuan Univ, West China Hosp, Dept Thorac Surg, 37 Guoxue Alley, Chengdu, Peoples R China
来源：
JOURNAL OF THORACIC DISEASE | 2021年 / 13卷 / 07期
关键词：
RECEPTOR EGFR MUTATION; OPEN-LABEL; 1ST-LINE ERLOTINIB; CHEMOTHERAPY; MULTICENTER; AFATINIB;
D O I：
10.21037/jtd-21-171
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：4554 / 4559
页数：6
相关论文
共 50 条
  • [31] Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
    Li, Xia
    Fan, Xing-Xing
    Jiang, Ze-Bo
    Loo, Wings T. Y.
    Yao, Xiao-Jun
    Leung, Elaine Lai-Han
    Chow, Louis W. C.
    Liu, Liang
    PHARMACOLOGICAL RESEARCH, 2017, 115 : 45 - 55
  • [32] Erlotinib response EGFR-mutant gefitinib-resistant non-small-cell lung cancer
    Chang, John Wen-Cheng
    Chou, Chun-Liang
    Huang, Shiu-Feng
    Wang, Hung-Ming
    Hsieh, Jia-Juan
    Hsu, Todd
    Cheung, Yun-Chung
    LUNG CANCER, 2007, 58 (03) : 414 - 417
  • [33] OsimertinibDevelopment of osimertinib resistance in non-small cell lung cancer with subsequent successful treatment with gefitinib: case report
    Reactions Weekly, 2017, 1661 (1) : 255 - 255
  • [34] Apoptotic effect of a single compound derived from natural product in Gefitinib-resistant non-small cell lung cancer cells
    Fan, Xing-Xing
    Wong, Maria Pik
    Cao, Zhi-Wei
    Li, Na
    Wu, Jin-Lin
    Zhou, Hua
    Jiang, Zhi-Hong
    Liu, Liang
    Leung, Elaine Lai-Han
    CANCER RESEARCH, 2014, 74 (19)
  • [35] Establishment of a human non-small cell lung cancer cell line resistant to gefitinib
    Koizumi, F
    Shimoyama, T
    Taguchi, F
    Saijo, N
    Nishio, K
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (01) : 36 - 44
  • [36] Manifestation of leukoencephalopathy in a patient with advanced non-small cell lung cancer following treatment with gefitinib
    HUANG YishengHUANG Biao and WU Yilong Guangdong Lung Cancer Institute Department of RadiologyGuangdong General Hospital and Guangdong Academy of Medical SciencesGuangzhou Guangdong China
    中华医学杂志(英文版), 2011, (22) : 3834 - 3837
  • [37] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [38] Manifestation of leukoencephalopathy in a patient with advanced non-small cell lung cancer following treatment with gefitinib
    Huang Yi-sheng
    Huang Biao
    Wu Yi-long
    CHINESE MEDICAL JOURNAL, 2011, 124 (22) : 3834 - 3837
  • [39] Gefitinib treatment for carcinomatous meningitis in Non-Small Cell Lung Cancer
    Chouahnia, K.
    Brechot, J. -M.
    Des-Guetz, G.
    Saintigny, P.
    Morere, J. -F
    Breau, J. -L.
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (02) : 149 - 151
  • [40] Salvage Surgery for Stage IV Non-Small Cell Lung Cancer
    Kojima, Hideaki
    Hayashi, Shoko
    Mizuno, Kiyomichi
    Yasuura, Yoshiyuki
    Shimizu, Reiko
    Kayata, Hiroyuki
    Takahashi, Shoji
    Isaka, Mitsuhiro
    Takahashi, Toshiaki
    Ohde, Yasuhisa
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S777 - S777
12345